ArriVent BioPharma Ownership | Who Owns ArriVent BioPharma?
ArriVent BioPharma Ownership Summary
ArriVent BioPharma is owned by 109.69% institutional investors, 2.77% insiders. Suvretta capital management is the largest institutional shareholder, holding 11.44% of AVBP shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 5.62% of its assets in ArriVent BioPharma shares.
AVBP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ArriVent BioPharma | 109.69% | 2.77% | -12.46% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.80% | 11.85% | 52.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Suvretta capital management | 4.40M | 11.44% | $101.53M |
| Infinitum asset management | 4.15M | 10.79% | $95.72M |
| Hhlr advisors | 3.93M | 10.22% | $90.64M |
| Orbimed advisors | 3.03M | 7.87% | $69.84M |
| Fmr | 3.02M | 7.84% | $69.58M |
| Blackrock funding, inc. /de | 2.53M | 6.58% | $58.37M |
| Octagon capital advisors lp | 1.97M | 5.12% | $45.47M |
| Novo | 1.94M | 5.05% | $44.81M |
| Vanguard group | 1.87M | 4.46% | $37.61M |
| Sofinnova investments | 1.70M | 4.41% | $39.14M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| General catalyst group management | 1.49M | 18.79% | $34.48M |
| Infinitum asset management | 4.15M | 11.95% | $95.72M |
| Hhlr advisors | 3.93M | 5.42% | $90.64M |
| Octagon capital advisors lp | 1.97M | 5.03% | $45.47M |
| Novo | 1.94M | 3.63% | $44.81M |
| Suvretta capital management | 4.40M | 2.59% | $101.53M |
| Vivo capital | 885.92K | 1.71% | $20.44M |
| Sofinnova investments | 1.70M | 1.49% | $39.14M |
| Orbimed advisors | 3.03M | 1.39% | $69.84M |
| Fund 1 investments | 499.99K | 1.32% | $11.53M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vivo capital | 885.92K | 1.71% | 885.92K |
| Point72 asset management | 748.20K | 0.02% | 531.53K |
| Balyasny asset management | 426.28K | 0.01% | 383.25K |
| Logos global management lp | 350.00K | 0.40% | 350.00K |
| State street | 1.42M | 0.00% | 329.44K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Siren | - | - | -700.00K |
| Fmr | 3.02M | 0.00% | -687.44K |
| Cormorant asset management, lp | - | - | -585.46K |
| Citadel advisors | 166.16K | 0.00% | -292.35K |
| Franklin resources | - | - | -256.42K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vivo capital | 885.92K | 1.71% | 885.92K | $20.44M |
| Logos global management lp | 350.00K | 0.40% | 350.00K | $8.07M |
| Nomura | 242.05K | 0.01% | 242.05K | $5.58M |
| Vanguard fiduciary trust | 217.13K | 0.00% | 217.13K | $5.01M |
| Polymer capital management (hk) | 122.28K | 0.24% | 122.28K | $2.82M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Clearstead advisors | -1.00 |
| Montag a & associates | -11.00 |
| Principal securities | -16.00 |
| Parkside financial bank & trust | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 143 | 18.18% | 42,190,288 | 5.19% | 109 | 1.20% | 91 | 26.39% | 28 | -17.65% |
| Dec 31, 2025 | 80 | -25.23% | 13,197,905 | -65.78% | 31 | 0.37% | 46 | -26.98% | 25 | 31.58% |
| Sep 30, 2025 | 105 | 8.25% | 38,570,317 | 14.70% | 110 | 1.19% | 63 | 26.00% | 18 | -40.00% |
| Jun 30, 2025 | 96 | 15.66% | 33,618,963 | 15.59% | 96 | 1.30% | 49 | 8.89% | 30 | 42.86% |
| Mar 31, 2025 | 7 | -91.14% | 11,264,335 | -59.25% | 35 | 0.53% | 4 | -92.98% | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| HBM Healthcare Investments AG Ord | 2.55M | 5.62% | 346.15K |
| Fidelity Select Biotechnology | 1.56M | 3.45% | -116.50K |
| Vanguard Total Stock Mkt Idx Inv | 1.16M | 2.55% | - |
| State Street® SPDR® S&P® Biotech ETF | 783.30K | 1.73% | -5.56K |
| iShares Russell 2000 ETF | 756.51K | 1.67% | 6.39K |
| Fidelity Growth Compy Commingled Pl S | 448.34K | 0.99% | 592.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 344.09K | 0.76% | 6.02K |
| Fidelity Growth Company Fund | 324.04K | 0.72% | - |
| Fidelity Small Cap Growth | 298.74K | 0.66% | - |
| Fidelity Small Cap Index | 289.95K | 0.64% | 3.62K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2025 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | - | Sell | $12.98M |
| Jan 30, 2024 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | - | Buy | $10.00M |
| Jan 30, 2024 | ORBIMED ADVISORS LLC | Buy | $4.00M | |
| Jan 30, 2024 | GORDON CARL L | Buy | $4.00M | |
| Jan 30, 2024 | HEALY JAMES | - | Buy | $8.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | 1 |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2024 Q1 | 4 | - |
AVBP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools